openPR Logo
Press release

Paclitaxel Injection Market: Competitive Dynamics & Global Outlook 2023

Paclitaxel Injection Market: Competitive Dynamics & Global

New report published by Market Research Report Store (MRRS) which offers insights on the global Paclitaxel Injection market.

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/1408/global-paclitaxel-injection-market-growth

Global Paclitaxel Injection Market: Forecast by Type / Application / Region

In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.

In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.

In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. What’s more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.

At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.

In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.

Over the next five years, LPI(LP Information) projects that Paclitaxel Injection will register a 11.0% CAGR in terms of revenue, reach US$ 3680 million by 2023, from US$ 2180 million in 2017.

Global Paclitaxel Injection Market: Key Players
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.marketresearchreportstore.com/reports/1408/global-paclitaxel-injection-market-growth

Related Information:
United States Paclitaxel Injection Market Research Report 2018
Europe Paclitaxel Injection Market Research Report 2018
North America Paclitaxel Injection Market Research Report 2018
Asia-Pacific Paclitaxel Injection Market Research Report 2018
China Paclitaxel Injection Market Research Report 2018
EMEA Paclitaxel Injection Market Research Report 2018
Global Paclitaxel Injection Market Research Report 2018

About Us:
Market Research Report Store (MRRS) is a professional organization related to market research reports in all directions .To provide customers with a variety of market research reports, MRRS cooperates with a large of famous market report publishers all over the world. Owing to our good service and the professional market reports in the wide range, MRRS enjoys a good reputation in the market. In pace with the development of MRRS, more and more customers and market report publishers choose to cooperate with us. As a specialized platform, MRRS upholds the supremacy of customers and aims to provide customers with better service and richer select.

Contact US :
Sales Director (Market Research Report Store)
E-mail: info@marketresearchreportstore.com
Tel: +86-15521064060 00852-58197708(HK)
Add: 17890 Castleton Street Suite 218 City of Industry CA 91748 United States
Website: https://www.marketresearchreportstore.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Paclitaxel Injection Market: Competitive Dynamics & Global Outlook 2023 here

News-ID: 1412035 • Views:

More Releases from Market Research Report Store

Global and United States Food Corrugated Box Packaging Market Report & Forecast …
This report focuses on global and United States Food Corrugated Box Packaging market, also covers the segmentation data of other regions in regional level and county level. Global Food Corrugated Box Packaging Scope and Market Size Food Corrugated Box Packaging market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Food Corrugated Box Packaging market will be able to gain the upper hand as they use
Polymer-coated Sulfur-coated Urea (PCSCU) Fertilizers Market Size, Share, Development by 2025
Polymer-coated Sulfur-coated Urea (PCSCU) Fertilizers Market Size, Share, Develo …
LP INFORMATION offers a latest published report on Polymer-coated Sulfur-coated Urea (PCSCU) Fertilizers Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This intelligence Polymer-coated Sulfur-coated Urea (PCSCU) Fertilizers Market report by LP INFORMATION includes investigations based on the current scenarios, historical records, and future predictions. An accurate data of various aspects such as type, size, application, and end user have
Global Micro and Mini LED Display Market Expected to Witness a Sustainable Growth over 2025
Global Micro and Mini LED Display Market Expected to Witness a Sustainable Growt …
Market Research Report Store offers a latest published report on Micro and Mini LED Display Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts and investments to maximize growth and profitability. The report presents the market competitive landscape and
Global COPD and Asthma Drug Devices Market to Witness a Pronounce Growth During 2025
Global COPD and Asthma Drug Devices Market to Witness a Pronounce Growth During …
Market Research Report Store offers a latest published report on COPD and Asthma Drug Devices Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts and investments to maximize growth and profitability. The report presents the market competitive landscape and

All 5 Releases


More Releases for Paclitaxel

Global Paclitaxel Market Study 2015-2025, by Segment (Natural Paclitaxel, Semi-s …
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents. The global Paclitaxel
Paclitaxel HPLC Global Market Research Report 2025
Paclitaxel HPLC Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-chemical/paclitaxel-hplc-market/81094 The report firstly introduced the Paclitaxel HPLC basics: definitions, classifications, applications and market
Paclitaxel Global Market Research Report 2025
Paclitaxel Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/paclitaxel-market-3/81092 The report firstly introduced the Paclitaxel basics: definitions, classifications, applications and market overview; product
Paclitaxel Injection Market Revenue Growth Predicted by 2026
The increasing prevalence of cancer is the major driving factor for the significant growth of this market. Paclitaxel injection has better efficiency for the treatment of cancer than other medication, besides that this is also easily available in the market which is responsible for the growth of this market. Major players of paclitaxel injection market are focusing on development of more improved paclitaxel injection which will be a remarkable opportunity
Global Paclitaxel Market Research Report 2017: Novasep, Samyang
In this report, the global Paclitaxel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Paclitaxel in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Fill
Paclitaxel Injection Market Snapshot by 2016 - 2026
Paclitaxel injection is a gelatinous drug, which is obtained from Pacific yew trees, after chemical synthesis process. It’s a sub-segment of antineoplastic drug class, used to cure cancer in breast, lungs, ovaries, stomach, cervix and other. Paclitaxel infection targets the tubulin, which is small globular protein in the human cell. It should be injected under the supervision of oncologist having experience in chemotherapy. It is not prescribed by the physician